---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-001508"
form_type: "8-K"
ticker: "SLSN"
cik: "0000883107"
company_name: "SOLESENCE, INC."
filed_at: "2024-03-21T23:59:59+00:00"
generated_at: "2026-06-04T11:04:55.655604+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nanophase Q4/FY2023 revenue flat at $37.3M; net loss widens to $4.4M; secures $6M financing

## Summary
- Q4 revenue $8.0M (vs $8.3M YoY); full-year revenue $37.3M flat; net loss $4.4M ($0.09/sh) vs $2.6M in 2022.
- Solésence revenue grew 9% to $25.2M; Personal Care Ingredients fell 17% to $9.3M; Advanced Materials fell 9% to $2.8M.
- Closed $6M financing package in March 2024 to support working capital and growth.
- Litigation costs contributed $1.3M to operating loss; company expects lower costs and positive resolution ahead.
- Management expects $35M in shipped and open POs so far in 2024, with more orders expected in Q2-Q3.

## SEC filing metadata
- accession: 0001171843-24-001508
- form_type: 8-K
- ticker: SLSN
- cik: 0000883107
- company_name: SOLESENCE, INC.
- filed_at: 2024-03-21T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883107/000117184324001508/0001171843-24-001508-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883107/000117184324001508/f8k_032024.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-001508
- JSON: https://secwatch.observer/filing/0001171843-24-001508.json
- Plain text: https://secwatch.observer/filing/0001171843-24-001508.txt

## Key facts
- Earnings Releases
  SOLESENCE, INC. reported the fourth quarter and fiscal year ended December 31, 2023 results: revenue $8 million, net income $2.1 million.
  - Period: the fourth quarter and fiscal year ended December 31, 2023
  - Revenue: $8 million
  - Net income: $2.1 million
  - Result: reported results
  source text: (PRESS RELEASE) --- EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Nanophase Reports Fourth Quarter and Year End 2023 Results, New Financing Package — Delivered $37.3 million in full year revenue — Closed on $6 million financing — Won 2024 Cosmetics and Toiletries Allē Award Finished Formula Prestige Category ROMEOVILLE, Ill., March 20, 2024 (GLOBE
  evidence_url: https://www.sec.gov/Archives/edgar/data/883107/000117184324001508/0001171843-24-001508-index.htm
- Earnings Releases
  SOLESENCE, INC. reported the fourth quarter and fiscal year ended December 31, 2023 results: revenue $8 million, net income $2.1 million.
  - Period: the fourth quarter and fiscal year ended December 31, 2023
  - Revenue: $8 million
  - Net income: $2.1 million
  - Result: reported results
  source text: and operations management efforts,” added Cureton. 2023 Q4 Financial Information Fourth Quarter and Full Year 2023 Financial Highlights Revenue for the fourth quarter was $8 million, vs. $8.3 million for the same period in 2022. Revenue for the full year was $37.3 million, which was the same for 2022. Additional capital was secured with a $6 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/883107/000117184324001508/0001171843-24-001508-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.